Thursday 30 November 2017

Oral Medications segment dominated the Compounding Pharmacies Market

The medical industry report “Compounding Pharmacies Market Size By Product (Oral, Topical, Rectal, Parenteral, Inhaler, Ophthalmic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Therapeutic Area (Hormone Replacement, Pain Management), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Russia, Poland, Greece, Ukraine, Sweden, Norway, Belgium, Czech Republic, Finland, China, India, Japan, Singapore, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa, Qatar, Kuwait), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024”, by Global Market Insights, Inc. says Compounding Pharmacies Market will hold a valuation of more than USD 12 billion by 2024, with an estimated CAGR of 5% over 2017-2024.

In an era of consequential transformation in the healthcare delivery, compounding pharmacies market is charting a profitable growth curve. Although a major chunk of pharmacists are involved in drug manufacturing, yet with the advancement of technology compounding has become an integral of pharmacy practice. The expanding geriatric population base along with increasing customized medication requirements subject to alternative doses, flavor, formulations are stimulating the market dynamics. In addition to this, the recent trend toward personalized diagnostic approach is expected to complement the business landscape in the years ahead. With the increasing drug shortage issues and drug failure rates in recent times, compounding pharmacies are anticipated to be the best alternative to address the growing drug demand.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/749  

The remarkable expansion of compounding pharmacies market is quite evident from its diversified product landscape which includes oral, rectal, inhaler, ophthalmic, topical, and parenteral. Oral medications procured the largest portion of the market share in 2015, and the trend is likely to continue in the years ahead.

Growing individual preference toward consuming medicines in the form of tablets, capsules have significantly propelled the market demand from this domain. Other than oral route, parenteral medications will also witness lucrative growth over 2017-2024, subject to the benefits associated with its compounding preparations. These intramuscular injections result in quick action to the body due to its localized drug application method.

Browse key industry insights spread across 192 pages with 150 market data tables & 14 figures & charts from this 2017 report Compounding Pharmacies Market in detail along with the table of contents at:


The prevalence of cardiovascular diseases has significantly risen among the adult population, which is likely to drive compounding pharmacies market. Sedentary lifestyles along with heavy consumption of fat-rich foods have led to a rise of these cardiac diseases, which in a way is stimulating the necessity of compounded medications. As per estimates, this sector accounted for the maximum industry share in 2016, and considering these aforementioned grounds, the trend is likely to continue in the years ahead. Pertaining to the increasing natality rates along with incapability of the commercial medicines to meet up with the customized pediatric formulation requirements, pediatric application will also register considerable revenue for compounding pharmacies market by 2024.

Speaking of technology, Japan compounding pharmacies market is highly influenced by the incorporation of hi-tech compounding processes. Adoption of automation in pharmacy compounding, presence of elderly population, and implementation of high-tech compounding devices in pharmaceutical sector can be together given the credit for the expansion of the regional market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/749

U.S. being one of the most progressive nations w.r.t healthcare infrastructure accounted for the largest compounding pharmacies industry share in 2016. Subject to the increasing drug deficiency in the country coupled with spreading consumer awareness about compounding medications, U.S. market is anticipated to witness a strong position in the global industry by 2024.

Compounding pharmacies market is characterized by some of the restraints such as lack of skilled lab personnel, excessive cost of the process, and issues related to its safety standards. To combat these threats, key market players are undertaking various collaborations to sustain their business position in the global industry. Some of the companies engaged in compounding pharmacies market include B. Braun Medical, PharMEDium, Fresenius Kabi, Village Compounding Pharmacy, and Cantrell Drug Company.

Browse Related Reports:

Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Wednesday 29 November 2017

Automated Immunoassay Analyzers industry analysis research and trends report for 2017-2024

The medical industry report “Automated Immunoassay Analyzers Market Size By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme Linked Fluorescent System, Multiplexed Assay System, Radioimmunoassay), By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024”, by Global Market Insights, Inc. says automated immunoassay analyzers are used heavily for drug monitoring in hospitals and clinics, slated to cross USD 25 billion with a CAGR projection of 15% over 2017-2024.

Renowned players operating in automated immunoassay analyzers market recently witnessed one of their co-participants, Thermo Fisher Scientific, the reputed American biotech company, launch a novel mass spectrometry-based clinical analyzer, called Thermo Scientific Cascadion. Known sources cite that the company has introduced this device as a tool that depicts the properties of convenient usage, robustness, and automation, as a combined characteristic that is far improved than that of a conventional immunoassay analyzer. With the launch of this product, Thermo Fisher Scientific has conveniently established itself as one of the global leaders operating in automated immunoassay analyzers industry. This business sphere is characterized by novel, technologically advanced product launches such as the aforementioned. Companies such as Siemens Healthcare, Abbott Diagnostics, Luminex Corporation, Biokit, Roche Diagnostics, and Biomerieux, which accumulate a major chunk of automated immunoassay analyzers market, have been focusing on expanding their product portfolio in terms of assay menu, automation level and test volumes, to come up with unique, innovative products and give a competitive edge to their rivals.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/1727

Automated immunoassay analyzers are basically deployed for carrying out various types of immunoassay testing for research and academic laboratories. They are used to test and diagnose infectious diseases, cardiological, endocrinological, and oncological diseases, and allergies. While the product has a massive application spectrum, infectious diseases accounted for the largest chunk of automated immunoassay analyzers market share in 2016. This may possibly be a result of the rising incidences of diseases caused due to infections, especially across the emerging economies. For instance, pneumonia is the leading cause of around 2 million deaths annually, causing the death of 1 in 5 children below the age of five. Improved healthcare infrastructure and the growing incidences of infections will further impel automated immunoassay analyzers industry size from infectious diseases, anticipated to cross USD 7 billion by 2024.

Chemiluminescence is one of the prominent analyzers that is widely used in techniques such as protein blotting, pharmacological tests, toxicological tests, and immunoassays. Chemiluminescence accounted for the largest share in automated immunoassay analyzers market in 2016, and is anticipated to witness extensive growth over the coming seven years. This growth can be credited to its accurate diagnosis and high sensitivity. Chemiluminescence is used in clinical immunology for studying inflammatory responses, immune response against drugs & pathogens, autoimmune diseases, and endocrine disorders, in hospitals and laboratories. Another analyzer, abbreviated ELISA (enzyme-linked immunosorbent assay), is also expected to witness considerable demand, owing to its affordable costs for an extensive test menu. Automated immunoassay analyzers industry size from ELISA is anticipated to surpass USD 6 billion by 2024, subject to its widespread usage in diagnostic and research & academic laboratories.

Browse key industry insights spread across 150 pages with 90 market data tables & 11 figures & charts from this 2017 report Automated Immunoassay Analyzers Market in detail along with the table of contents at:


Speaking along similar lines, hospitals held the largest chunk of automated immunoassay analyzers market share in 2016, and will increase considerably over the coming years. This growth can be attributed to favorable healthcare related norms for delivering optimum medical care. Subject to the rising number of educational institutes and the benefits of automated systems, automated immunoassay analyzers industry size from diagnostic laboratories is expected to witness the maximum growth rate over 2017-2024.

Automated immunoassay analyzers market is slated to witness excellent growth prospects across myriad geographies. China automated immunoassay analyzers industry for instance, is projected to observe the highest gains over the oncoming seven years, primarily due to the massive patient base and enhanced healthcare infrastructure in the region. Besides, the penetration of leading manufacturers in APAC will provide multiple opportunities for the growth of regional automated immunoassay analyzers markets such as India and China.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1727

The United States does not stand far behind when it comes to the expansion of automated immunoassay analyzers industry. U.S. accounted for more than 90% of North America automated immunoassay analyzers market in 2016, and is predicted to grow massively over the coming seven years, subject to the extensive adoption of automation trends and favorable government norms.

Automated immunoassay analyzers are heavily used in laboratories, hospitals, clinics to perform biochemical tests with a view to detect and predict the concentration of a substance in the test samples. Of late, small laboratories have been facing the brunt of increased costs, owing to the rapidly changing trends of automation. Since small labs do not adapt quickly to technological changes, protocol changes, staff training, and system revaluation, automated immunoassay analyzers industry has been facing a minor hindrance in terms of costs associated with the shifting of conventional products to automated product. In all likeliness, the constraint may be overcome if manufacturers strive to introduce suitable replacement systems or budget-friendly analyzer systems. In addition, manufacturers have been striving to focus on multiplex technologies using protein and peptide arrays to launch multi-parametric assays systems, thereby contributing toward the positive growth of automated immunoassay analyzers market.

Browse Related Reports:

Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Monday 27 November 2017

Pet Cancer Therapeutics Market share to exceed $300mn by 2024

Launching of Tanovea-CA1, the FDA approved animal drug for treating canine lymphoma is indeed a breakthrough in pet cancer therapeutics market. Synonymous with lymphosarcoma, this detrimental disease is the most common type of cancer affecting dogs. Center for Veterinary Medicine, a subsidiary of U.S Food and Administration has recently announced a partial approval to this groundbreaking anti-cancer drug and depending upon the effectiveness, market experts anticipates its full approval within few years. A Colorado State University startup, VetDC Inc., is commercially merchandizing these drugs and are presently available in the U.S. market by licensed veterinarians. Reportedly, TANOVEA-CA1 is the only effective animal drug available in pet cancer therapeutics market for the treatment of lymphoma.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/2017   

In veterinary oncology, chemotherapy is the most recognized therapeutic model that is extensively deployed as one of the most relatively effective methodologies of treatment. In fact, in 2016, chemotherapy held the largest share of the overall pet cancer therapeutics industry. However, as stated by a reputed pet care organization, the goal of chemotherapy treatment in veterinary patients is slightly different from that of human patients. In case of pet cancer treatment, outgrowth of cancer cells is tried to limit as much as possible but not at the cost of their quality of life. However, it has been noticed that cats and dogs respond to chemotherapy much better than humans, which again is pushing pet cancer therapeutics market from chemotherapy.

Browse key industry insights spread across 95 pages with 80 market data tables & 9 figures & charts from this 2017 report Pet Cancer Therapeutics Market in detail along with the table of contents at:


Funding impacting the pet cancer therapeutics industry dynamics:

Blue Buffalo Foundation and The Petco Foundation have entered a partnership to provide a grant of USD 750000 to Morris Animal Foundation. Reportedly this grand sum of investment is an initiative taken to fund Morris Animal Foundation’s research initiative related to osteosarcoma and other additional studies related to pet cancer. Out of the total grant, USD 500000 is reported to invest in the Foundation’s Osteosarcoma Initiative. Surveys depict that osteosarcoma is a belligerent tumor that is most frequently detected in dogs. The lumpsum grant unquestionably will bring an awareness that would result in an enhancement in the pet cancer therapeutics industry outlook.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2017

As per a recent report put forward by Global Market Insights, Inc., Pet cancer therapeutics market is forecast to exceed a revenue of USD 300 million by 2024, with a projected CAGR of 10% over 2017-2024.  Some of the prominent biggies in the pet cancer therapeutics market include Zoetis, Aratana Therapeutics Merial, AB Science, VetDC, Vetivax, Karyopharms Verdinexor, and Regeneus. The industry is rather new and is rapidly expanding with regards to product development and expansive pool of veterinary patients affected with cancers. Though the fraternity till date has been substantially dominated by leading pharmaceutical giants, pet cancer therapeutics industry is poised to carve a profitable road map in the years ahead with a plethora of new entrants specialized in pet cancer therapy.  


Animal Healthcare Market Size By Pharmaceuticals (Ectoparasiticides, Endoparasiticides, Anti-inflammatories, Anti-infectives), By Vaccines (Poultry, Cattle, Swine, Equine, Dogs, Cats, Horses), By Medicated Feed Additives( Antibiotics, Vitamins, Amino acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals), By Animal Type ( Farm Animal And Companion Animal), Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, Poland, Netherlands, China, Japan, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Technology Development, Competitive Landscape & Forecast, 2017 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us:
Facebook | Google+ | LinkedIn | Twitter

Sunday 26 November 2017

Analysis of Vaccines Market applications and companies active in the industry

The research report “Global Vaccines Market Size By Age Group (Pediatric, Adult), By Technology (Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant,), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), Regional Outlook (U.S., Canada, Germany, UK, Spain, Russia, Italy, France, China, Japan, India, Indonesia, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Qatar, Egypt), Technology Development, Competitive Landscape & Forecast, 2017 – 2024” by Global Market Insights, Inc. says, in 2016, vaccines market size stood at a revenue of USD 32 billion.

The global vaccines market has recently witnessed one of its key participants, Novartis NVS announcing its decision to acquire the France based radiopharmaceutical company, Advanced Accelerator Applications (AAAP). This purchase apparently, is expected to strengthen Novartis’ product portfolio in the cancer vertical, by adding AAAP’s RadioLigand Therapy. Novartis reportedly has been investing heavily to develop vaccines for several kinds of cancers, given the severity of this terminal disease and the efficacy of the right vaccine to prevent the same. In this regard, to reduce the massive death rates across the globe due to nearly untreatable disorders, the World Health Organization (WHO) had also organized a Global Vaccine Action Plan in 2012, with the intention of preventing millions of deaths by 2020, by providing access to vaccines for major ailments. An initiative of this level, in conjunction with other initiatives organized by regional governments is anticipated to considerably spur vaccines industry share.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/2186

Currently, it has been observed most of the pharmaceutical giants have been striving to come up with innovative vaccination products for influenza, which seems to be raging across the globe in seasonal intervals. Recently, one of the prominent UK-based suppliers of seasonal influenza vaccines, and a renowned giant in vaccines industry, Seqirus invested USD 52.5 million in its plant at Liverpool to increase the production capacity of Fluad, its adjuvanted seasonal flu vaccine. The company also plans to recruit more workforce to increase the production rate, so that the vaccines can be shipped in readiness in case of a pandemic. Seqirus’s investment is likely to encourage regional vaccines industry players to follow suit, which would subsequently help stimulate UK vaccines market trends over the coming years.

Browse key industry insights spread across 140 pages with 108 market data tables & 9 figures & charts from this 2017 report Vaccines Market in detail along with the table of contents at:


Regulatory organizations have been making continuous efforts to generate awareness among the global populace regarding the advantages of vaccination. For instance, the U.S. Centers for Disease Control and Prevention (CDC) has inked guidelines to encourage people to take seasonal influenza vaccines for controlling and preventing the virus from spreading, especially in young children, the elderly, and pregnant women. In fact, CDC reports that post the implementation of vaccination programs, the percentage of people afflicted with influenza had decreased significantly across the U.S. As per estimates, U.S. covered a major share of the regional vaccines market revenue in 2016, pertaining to the numerous efforts undertaken by regulatory bodies.

Considering the myriad advantages that vaccines provide to improve an individual’s immunity system, researchers have been striving to conduct eminent study programs involving the methodology of combining vaccines with other cancer treatment methods such as radiations, chemotherapy, and Herceptin to enhance patient survival rate. Recently for instance, APAC vaccines market had witnessed an Australian company developing vaccines for breast and gastric cancer, the trials of which have depicted an affirmative result. The approval of this vaccine is likely to prove highly beneficial for cancer afflicted patients, and subsequently, is expected to provide a positive impetus to the regional vaccines market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2186

Notable behemoths across the vaccines market, namely, Merck & Co., AstraZeneca, Pfizer, Novartis, Bristol-Myers Squibb, CSL, Johnson & Johnson, Abbott, GlaxoSmithKline, Astellas Pharma, Sanofi Pasteur, Novavax, and Emergent BioSolutions, have been depicting considerable interest in R&D investments in order to brainstorm innovative products for disease prevention. With their efforts bearing fruit, vaccines market is expected to demonstrate a massive rise in its revenue graph over 2017-2024, additionally driven by commendable government initiatives to promote vaccination programs.

Browse Related Reports:

Preventive and Therapeutic Vaccine Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Russia, China, India, Japan, Malaysia, Thailand, Indonesia, Australia, Brazil, Saudi Arabia, UAE, South Africa), Application Growth Potential, Competitive Market Growth & Forecast, 2017 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Wednesday 22 November 2017

Inhalation Anesthesia Market to grow at 3.5% CAGR from 2017 to 2024

In what may be construed as a breakthrough in inhalation anesthesia market, Baxter International Incorporation, a medical products manufacturer, has collaborated with Dorizoe Lifesciences Limited, a CRO firm, to develop over twenty generic injectable high-quality products comprising oncolytics, cardiovascular medicines, and anti-infectives. Baxter had already made it to the headlines earlier this year for its acquisition of Claris injectables limited, a key player across inhalation anesthesia industry, in a bid to expand its geographical presence.

Apparently, Claris’ inclusion in its acquisition fold would help the firm consolidate their portfolio of anesthesia and analgesics drug products. Baxter’s unpretentious but powerful penetration in inhalation anesthesia industry underlines its commitment toward the medical and pharma verticals. Driven by the commendable efforts of medical companies and the robust prevalence of chronic ailments leading to the subsequent demand for anesthetics, inhalation anesthesia market size was pegged at USD 1,285.8 million in 2016.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/704

The product landscape of inhalation anesthesia market comprises isoflurane, sevoflurane, and desflurane – essential anesthetics used during crucial surgeries. Sevoflurane among these, is renown to have contributed significantly towards inhalation anesthesia industry revenue in 2016. Subject to favorable product features such as low flammability and intrinsic stability, sevoflurane inhalation anesthesia market share is set to witness a commendable expansion over the next few years. Its counterpart – isoflurane is mostly preferred in neurosurgeries due to its ability to potentiate muscle relaxant activity and assist the expansion of systemic vessels.

Considering the rising prevalence of chronic diseases such as cancer across the U.S., in tandem with the high-grade healthcare infrastructure and medical care expenditure of the country, it comes as no surprise that the United States is one of most remunerative avenues for inhalation anesthesia market. Estimates claim that the U.S. dominated the regional market share in 2016, driven by the surging product deployment in plastic surgeries and the growing prevalence of chronic lower respiratory ailments.

Browse key industry insights spread across 130 pages with 168 market data tables & 9 figures & charts from the report Inhalation Anesthesia Market in detail along with the table of contents:


Pertaining to the widespread applications of the product, inhalation anesthesia market has successfully established its presence across many other geographies across the globe, apart from the U.S. Europe inhalation anesthesia industry size for instance, impelled by the thriving economies of UK and Germany, is likely to chart out a profitable growth path in the years ahead. UK, in particular, will register a substantial growth rate over 2017-2024, given the rising prevalence of cancer and the rapidly increasing rate of surgical procedures.

Germany apparently, accounted for the highest share in the Europe market, driven by the growing geriatric population suffering from chronic ailments. In fact, as per estimates, cancer and cardiovascular disorders account for more than 66% of deaths in the country –  a factor which is slated to upsurge the demand for anesthesia in surgeries, inherently propelling Germany inhalation anesthesia industry size.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/704

Inhalation anesthesia market, touted to be one of most profitable business spheres of recent times, has its share of restraints, one of principal ones being, the ill-effects of anesthetic products. Pertaining to the same, companies have been brainstorming ways to innovate contemporary products as per the illness and the level of its seriousness in question.

In essence, the undertaking of strategic initiatives and the growing R&D funding are expected to successfully complement inhalation anesthesia market outlook in the forthcoming years. If estimates are to be believed, this business vertical is anticipated to generate a target valuation exceeding USD 1.6 billion by 2024.

Browse Related Reports:

Therapeutic Respiratory Devices Market Size By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Ventilators, Gas Analyzers, Capnographs), By Technology (Electrostatic Filtration, HEPA, Hollow Fiber Filtration, Microsphere Separation), By Filters (Nebulizer, Humidifier, Positive Airway Pressure Device, Oxygen Concentrator, Ventilator Filters), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, Switzerland, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Tuesday 21 November 2017

Body Fat Measurement Market to see growth of 8% from 2016 to 2024

The medical report “Body Fat Measurement Market Size By Product (Bioimpedance Analyzers, Body Fat Skinfold Calipers, Air Displacement Plethysmography, Hydrostatic Weighing, Dual Emission X-ray Absorptiometry), Industry Analysis Report, Regional Outlook (U.S., UK, Germany, China, Japan, Mexico, Brazil, South Africa), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., Body fat measurement industry revenue, worth USD 402.6 million in 2015, is set to hit USD 798 million by 2024.

High awareness about health & fitness along with the rise in the number of gyms & health clubs will spur body fat measurement market growth. Rising cases of metabolic dysfunctions and obesity along with high demand for modern BIA equipment will contribute remarkably towards the business revenue. As per CDC (Centers for disease control and prevention) over 36.5% of adult population in the U.S. were obese during the period of 2011-2014 and the projected overall medical costs in the country amounted to USD 147 billion in 2008.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/772


Taking into consideration the topographical landscape, U.S. body fat measurement industry, which accumulated a revenue of over USD 146 million in 2015, is predicted to hit USD 274 million by 2024. Large patient population affected by obesity and increase in the percentage of people undergoing fitness training activities to remain healthy will drive the regional share.

Browse key industry insights spread across 80 pages with 95 market data tables & 14 figures & charts from this 2017 report Body Fat Measurement Market in detail along with the table of contents at:


Asia Pacific body fat measurement market is predicted to grow at an annual rate of 8.9% over the coming seven years, supported by high purchasing power along with heavy investments across healthcare sector. Japan, India, and China are likely to be the major regional revenue drivers.

Body fat measurement industry size in Europe, evaluated at USD 126.7 million in 2015, is forecast to observe a noticeable expansion over the coming years. The growth can be attributed to favorable government policies predicted to build a strong foundation/base for healthcare sector. UK and Germany are projected to drive the regional growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/772

Dual Emission X-ray Absorptiometry, Bioimpedance Analyzers, Air Displacement Plethysmography, Hydrostatic Weighing, and Body Fat Skinfold Calipers are the key products of body fat measurement industry. Bioimpedance analyzers, which amassed a revenue of USD 144 million in 2015, are expected to significantly drive body fat measurement market share over the next few years. Introduction of new technologies to enhance the level of accuracy along with effective caliper & hydrostatic weighing blend will drive the product demand.

Market players will try to enhance their geographical presence and ROI through product differentiation and high investments in R&D activities for introducing new/additional product features. AccuFitness LLC, L’Accessorio Nuclear S.r.l., GE Healthcare, COSMED, Jawon Medical Company Limited, Hologic Incorporation, Beurer GmbH, Inbody Company Limited, The Diagnostic Medical Systems Group, Tanita Corporation, Exertech, and Omron Global are the major participants of body fat measurement industry.


Intragastric Balloon Market Size By Product (Single, Dual, Triple), By Filling Material (Saline, Gas), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, Russia, Poland, Japan, India, China, Australia, Malaysia, Indonesia, Thailand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Egypt), Application Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter